ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Funds Two Carcinogens And A Threat To Humans

March 17, 1978

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

NCI Budget 6% Below 1980 Level; Prevention, Groups, Lost Most

February 8, 1991

JR Adams Elected President, Ovarian Cancer Coalition.

March 9, 2001

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

IOM Report Calls For FDA Authority Nutritional Supplement Health Claims

May 21, 2010